← Every company
Otsuka Holdings Co Ltd Patents
What Otsuka Holdings Co Ltd has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
OTSKY on carbonthat →Filings on file
57
Granted
1
Still pending
56
Filed under
16 names
57 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| METHODS AND SYSTEMS FOR DETERMINING BODY LUMEN SIZEA61B 5/1076, A61B 90/06, A61B2090/061, A61B2090/064, A61B 5/6853, A61B 5/7271, A61B 18/1492, A61B2018/0022, A61B2018/00404, A61B2018/00577, A61B2562/168, A61N 7/022, A61N2007/0021, A61N2007/003, A61N2007/0043Filed as Otsuka Medical Devices Co., Ltd.2026-06-11Liang Zhai | pending |
| TRANSMITTING ACOUSTIC AND ELECTROMAGNETIC SIGNALS FROM A CATHETER BALLOONA61B 18/1492, A61B2018/00261, A61B2018/00577, A61B2018/00732Filed as Otsuka Medical Devices Co., Ltd.2026-06-05Liang Zhai | pending |
| TISSUE TREATMENT CATHETER HAVING SUPPORTIVE ISOLATION TUBEA61B 18/1492, A61M 25/09, A61B2018/00285, A61B2018/00375, A61B2018/00434, A61B2018/00511, A61B2018/00577, A61B2018/00994, A61M2025/09008, A61N 7/02, A61N2007/003, A61N2007/025Filed as Otsuka Medical Devices Co., Ltd.2026-04-29James D. Mazzone | pending |
| MEDICAL TUBE POSITION CONFIRMATION SYSTEMA61B 34/20, A61J 15/0026, A61J 15/0088, A61B2034/2055, A61B2090/3945, A61B 5/065, A61J 15/0003Filed as OTSUKA CLINICAL SOLUTIONS, INC.2026-04-21Shinya MIIKE | pending |
| MEASUREMENT PROCESSING APPARATUS, MEASUREMENT METHOD, AND STORAGE MEDIUMG01B 11/0625Filed as Otsuka Electronics Co., Ltd.2026-03-20Sota OKAMOTO | pending |
| STORAGE LIQUID FOR MAMMALIAN CELLSC12N 1/04, C12N 5/0644, C12N 5/0622, C12N 5/0636, C12N 5/0662, C12N 5/0663, C12N2500/34, C12N2500/38, C12N2500/84, C12N2501/60, C12N2501/606, C12N2506/45Filed as OTSUKA PHARMACEUTICAL FACTORY, INC.2026-03-18Junko TOMIZUKA | pending |
| CATHETER HAVING COMPLIANT BALLOONA61M 25/1002, A61N 7/022, A61B2017/22068, A61B2018/00023, A61B2018/00285, A61B2018/00404, A61B2018/00434, A61B2018/00511, A61B2018/00577, A61B2018/00744, A61M 25/1018, A61M2025/1068, A61M2205/0216, A61N 7/02, A61N2007/0026, A61N2007/003, A61N2007/0043Filed as Otsuka Medical Devices Co., Ltd.2026-03-12James D. Mazzone | pending |
| COMPLEMENT PATHWAY INHIBITOR POLYPEPTIDES AND METHODS OF USE THEREOFC07K 16/18, A61P 37/06, A61K 38/00, A61K2039/505, C07K 14/70596, C07K2317/22, C07K2317/33, C07K2317/52, C07K2317/524, C07K2317/53, C07K2317/565, C07K2317/569, C07K2317/76, C07K2317/92, C07K2319/00, C12N 15/86, C12N2750/14143Filed as Otsuka Pharmaceutical Co., Ltd.2026-03-06Boopathy Ramakrishnan | pending |
| COMPOUNDS USEFUL FOR THE TREATMENT OF DISORDERS AND METHODS RELATED THERETOFiled as OTSUKA AMERICA PHARMACEUTICAL, INC.2026-03-05ABDELMALIK SLASSI | pending |
| OPTICAL MEASUREMENT SYSTEM AND OPTICAL MEASUREMENT METHODG01B 11/2441, G01B 9/02022, G01B 9/02032, G01B 9/02047, G01B 9/02075, G01B 9/02083, G03H 1/0443, G03H 1/0866, G03H2001/0033, G03H2001/0445, G03H2001/0454, G03H2001/0473Filed as Otsuka Electronics Co., Ltd.2026-03-03Kensaku SHIMODA | pending |
| DEVICE FOR TREATING CANCERFiled as Otsuka Medical Devices Co., Ltd.2026-01-30Neil BARMAN | pending |
| CRYSTALLINE COMPOUNDSC07D 209/52, A61P 25/14, A61P 25/30, A61P 25/22, A61P 25/24, A61P 25/00, A61K 31/403, C07B2200/13, C07C 211/17Filed as OTSUKA AMERICA PHARMACEUTICAL, INC.2026-01-12Anthony McKinney | pending |
| OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITIONA61K 31/421, C07D 263/32, C07D 263/34, A61P 27/02, A61P 37/00, A61P 17/06, A61P 25/28, A61P 43/00, A61P 11/06, A61P 17/14, A61P 25/22, A61P 17/00, A61P 19/02, A61P 37/08, A61P 25/18, A61P 25/24, A61P 27/16, A61P 11/00, A61P 25/16, A61P 29/00, A61P 1/04, A61K 31/422, A61K 31/4439, A61K 31/4709, A61K 31/496, A61K 31/497, A61K 31/5377, C07D 413/06, C07D 413/12, C12N 9/16, C12Y 301/04012Filed as OTSUKA PHARMACEUTICAL CO., LTD.2025-12-17Minoru OKADA | pending |
| TABLET COMPRISING 7-[4-(4-BENZO[B]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOFA61K 9/0056, A61K 31/496, A61P 43/00, A61P 25/18, A61K 9/2013, A61K 9/2018, A61K 9/205, A61K 9/2054, A61K 9/2059, A61K 9/2813, A61K 9/2866Filed as OTSUKA PHARMACEUTICAL CO., LTD.2025-12-14Yoshiharu INOUE | pending |
| AGENT FOR PROMOTING ENERGY CONSUMPTIONA61K 31/4015, A61P 3/00, A61P 3/04Filed as OTSUKA PHARMACEUTICAL FACTORY, INC.2025-12-11Ippei YAMAOKA | pending |
| NATURAL LANGUAGE PROCESSING AND MACHINE LEARNING MODELS FOR NON-COMPLIANCE DETECTIONFiled as OTSUKA AMERICA PHARMACEUTICAL, INC.2025-12-05JANET AHN | pending |
| METHODS OF TREATING SJOGREN'S DISEASEC07K 16/2875, A61P 37/06, A61K 9/0019, A61K 31/42, A61K 31/4706, A61K 31/519, A61K 31/52, A61K 31/573, A61K 38/00, A61K2039/505, A61K2039/545, C07K2317/24, C07K2317/565, C07K2317/76Filed as OTSUKA AMERICA PHARMACEUTICAL, INC.2025-12-02Jeffrey HAFKIN | pending |
| METHODS OF TREATING SJÖGREN’S DISEASEFiled as OTSUKA AMERICA PHARMACEUTICAL, INC.2025-12-02JEFFREY HAFKIN | pending |
| YELLOW AZO PIGMENT-CONTAINING COLORING COMPOSITION AND PRODUCTION METHOD OF THE SAMEC09D 11/322Filed as OTSUKA CHEMICAL CO., LTD.2025-11-28Tatsuhiko SHIMIZU | pending |
| MAGNESIUM POTASSIUM TITANATE, FRICTION ADJUSTING MATERIAL, FRICTION MATERIAL COMPOSITION, FRICTION MATERIAL, AND FRICTION MEMBERF16D 69/026, C01G 23/006, C01P2002/50, C01P2002/82, C01P2004/04, C01P2004/20, C01P2004/61, C01P2004/62, C01P2006/12, F16D2200/0065Filed as OTSUKA CHEMICAL CO., LTD.2025-11-25Yasuhito Ito | pending |
| IN-VITRO TISSUE MODEL AND TEST METHODC12N 5/0652, G01N 33/5082, A61B 18/1492, A61B 18/1815, A61B 18/28, A61B2017/00725, A61B2018/0022, A61B2018/00577, A61B2018/00779, A61B2018/00845, A61B2018/00863, A61N 7/02, A61N2007/003, C12N2503/04, G01N 33/5061Filed as Otsuka Medical Devices Co., Ltd.2025-11-17Liang ZHAI | pending |
| ANTI-IL1RAP ANTIBODIESC07K 16/2866, A61P 35/00, G01N 33/5759, C07K2317/33, C07K2317/52, C07K2317/565, C07K2317/732, C07K2317/76, C07K2317/92, G01N2333/7155Filed as OTSUKA PHARMACEUTICAL CO., LTD.2025-11-04Camilla Rydberg MILLRUD | pending |
| MEDICAL DEVICE CONTAINING A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT, AND A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENTA61K 9/19, A61M 5/19, A61P 25/18, A61K 9/0019, A61K 9/0024, A61K 9/10, A61K 31/496, A61M 5/284, A61M 5/31, B65B 3/00, F04C2270/0421Filed as OTSUKA PHARMACEUTICAL CO., LTD2025-10-31Shogo HIRAOKA | pending |
| METHODS OF TREATING SJOGREN'S DISEASEFiled as OTSUKA AMERICA PHARMACEUTICAL, INC.2025-10-28Jeffrey HAFKIN | pending |
| INHIBITOR OF MEGAKARYOCYTE DIFFERENTIATION AND MATURATIONA61K 31/50, A61K 31/513, C07D 237/04, A61P 7/00, A61P 7/02, A61P 37/02Filed as OTSUKA PHARMACEUTICAL CO., LTD.2025-10-14Emiri TAKAKI | pending |
| PHARMACEUTICAL COMPOSITIONA61P 17/02, A61K 35/28, A61P 9/10, A61P 11/00, C12N 5/0663Filed as OTSUKA PHARMACEUTICAL FACTORY, INC.2025-10-10Shohta KODAMA | pending |
| METHODS FOR DOSE INITIATION OF ARIPIPRAZOLE TREATMENTSA61K 9/0019, A61K 31/496, A61P 25/18, A61K 9/0053, A61K 47/10, A61K 47/32, A61K 47/38Filed as OTSUKA PHARMACEUTICAL CO., LTD.2025-10-08Matthew HARLIN | 12691056 |
| CRYSTALLINE COMPOUNDSFiled as OTSUKA AMERICA PHARMACEUTICAL, INC2025-10-03Anthony McKinney | pending |
| COLONY STIMULATING FACTOR 1 RECEPTOR ANTIBODIES AND METHODS OF USE THEREOFC07K 16/2866, A61P 27/02, A61K 48/0033, A61K 48/005, A61K2039/505, A61K2039/54, A61K2039/545, C07K2317/22, C07K2317/24, C07K2317/33, C07K2317/569, C07K2317/76, C07K2317/92, C12N 15/86, C12N2750/14143Filed as Otsuka Pharmaceutical Co., Ltd.2025-09-17Shingo Nishikori | pending |
| PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTSA61K 31/496, C07D 409/12, A61P 25/20, A61P 25/28, A61P 25/22, A61P 3/04, A61P 25/04, A61P 25/18, A61P 25/24, A61P 25/00, A61P 25/16, A61P 1/08, A61P 25/06, A61K 31/501, A61K 31/506, A61K 31/5377, A61K 31/541, A61K 31/675, A61K 31/695, C07D 409/14, C07F 7/1804Filed as OTSUKA PHARMACEUTICAL CO., LTD.2025-09-12Hiroshi YAMASHITA | pending |
| OPTICAL MEASUREMENT DEVICE, OPTICAL MEASUREMENT METHOD AND OPTICAL MEASUREMENT PROGRAMG06T 7/75, G01S 17/89, G06T 7/521, G06T 7/344, G06T 7/73, G06T 7/70, G01B 11/00, G01B 11/26, G06T2207/10028Filed as OTSUKA MECHATRONICS CO., LTD.2025-09-11Yasuharu OBA | pending |
| COMPOUNDS TARGETING MUTATIONS IN P53 AND USES THEREOFA61K 31/675, A61P 35/00, A61K 31/437, A61K 31/438, A61K 31/444, A61K 31/4545, A61K 31/5377, C07B 59/002, C07B 59/004, C07D 471/04, C07F 9/6561Filed as Otsuka Pharmaceutical Co., Ltd.2025-09-05Alexander PASTERNAK | pending |
| HETEROCYCLIC COMPOUND AND USE THEREOFC07F 9/65586, A61P 25/20, A61P 25/28, A61P 43/00, A61P 25/22, A61P 25/18, A61P 25/24, A61P 25/00, A61P 25/16, A61K 9/0019, A61K 9/0024, A61K 9/06, A61K 9/08, A61K 9/10, A61K 9/1274, A61K 9/1647, A61K 31/675, A61K 47/02, A61K 47/14, A61K 47/24, A61K 47/26, A61K 47/38, C07F 9/6561Filed as OTSUKA PHARMACEUTICAL CO., LTD.2025-09-05Nobuaki ITO | pending |
| SELECTIVELY INSULATED ULTRASOUND TRANSDUCERSA61B 17/320068, A61N 7/00, A61B2017/320069, H10N 30/2027, H10N 30/883, A61B 17/2202, A61B2017/00402, A61B2017/00831, A61B2017/00929, A61B2017/22062, A61B2018/00023, A61B2018/0022, A61N2007/0026, A61N2007/003, A61N2007/0043, B06B 1/0655, B06B2201/76Filed as Otsuka Medical Devices Co., Ltd.2025-08-29Shruthi R. Thirumalai | pending |
| INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND INFORMATION PROCESSING PROGRAMG06F 3/04847, G06F 3/0481, G06F 3/04855, G06F 3/0487Filed as OTSUKA ELECTRONICS CO., LTD.2025-08-26Kensaku SHIMODA | pending |
| PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERSFiled as Otsuka Pharmaceutical Co., Ltd.2025-08-22Iain LINGARD | pending |
| PYRIMIDINE COMPOUNDA61P 25/08, A61K 31/513, C07D 239/22, C07D 403/04, C07D 239/54, C07D 401/14, C07F 7/0812Filed as OTSUKA PHARMACEUTICAL CO., LTD.2025-08-08Tomoichi SHINOHARA | pending |
| SYSTEMS AND METHODS FOR TREATING A MENTAL CONDITION USING A DIGITAL THERAPEUTICFiled as OTSUKA PRECISION HEALTH, INC.2025-08-05AINSLIE FORBES | pending |
| COMPOUNDS USEFUL FOR THE TREATMENT OF DISORDERS AND METHODS RELATED THERETOFiled as OTSUKA AMERICA PHARMACEUTICAL, INC2025-07-30ABDELMALIK SLASSI | pending |
| LINKER FOR ANTIBODY-DRUG CONJUGATES, AND ANTIBODY-DRUG CONJUGATEFiled as OTSUKA PHARMACEUTICAL CO., LTD.2025-07-15Keisuke MAKI | pending |
| TAU SPLICE-SWITCHING OLIGONUCLEOTIDE AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING TAU-RELATED DISEASEA61P 25/00, A61K 31/7088, C12N 15/113, A61P 27/02, A61P 27/06, A61P 25/28, A61P 25/08, A61P 25/16, A61K 31/711, A61K 31/7115, A61K 31/712, A61K 31/7125, A61K 31/713, A61K 48/00, C12N2310/11, C12N2310/14, C12N2310/315, C12N2310/321, C12N2310/3231, C12N2310/3341, C12N2310/341, C12N2320/33Filed as OTSUKA PHARMACEUTICAL CO., LTD.2025-07-11Shunya SUZUKI | pending |
| COMPOUNDS USEFUL FOR THE TREATMENT OF DISORDERS AND METHODS RELATED THERETOFiled as OTSUKA AMERICA PHARMACEUTICAL, INC.2025-07-08ABDELMALIK SLASSI | pending |
| COMPOUNDS USEFUL FOR THE TREATMENT OF DISORDERS AND METHODS RELATED THERETOFiled as OTSUKA AMERICA PHARMACEUTICAL, INC.2025-07-01ABDELMALIK SLASSI | pending |
| COMPOUNDS USEFUL FOR THE TREATMENT OF DISORDERS AND METHODS RELATED THERETOFiled as OTSUKA AMERICA PHARMACEUTICAL, INC.2025-07-01ABDELMALIK SLASSI | pending |
| MEDICAL CAP, MEDICAL CONTAINER, AND PRODUCTION METHOD FOR MEDICAL CONTAINERA61J 1/1425, A61J 1/1412, A61J 1/1468, A61J 1/05, A61J 1/1406, B65D 41/28, B65D 51/00, B65D 51/002Filed as OTSUKA PHARMACEUTICAL FACTORY, INC.2025-06-27Hiroyuki TAGATA | pending |
| MEDICAL CAP, MEDICAL CONTAINER, AND METHOD FOR MANUFACTURING MEDICAL CAPA61J 1/1425, A61J 1/1406, B29C 45/72, B65D 41/28, B65D 51/002Filed as OTSUKA PHARMACEUTICAL FACTORY, INC.2025-06-27Hiroyuki TAGATA | pending |
| CENTANAFADINE PHARMACEUTICAL FORMULATIONS, AND METHODS OF MAKING AND USING SAMEA61K 9/167, A61K 9/5073, A61P 25/00, A61P 25/26, A61K 9/1611, A61K 9/1617, A61K 9/1623, A61K 9/1635, A61K 9/1652, A61K 9/5084, A61K 31/403Filed as OTSUKA PHARMACEUTICAL CO., LTD.2025-06-25Syed Asfar Mateen | pending |
| METHOD OF DETECTING CONJUNCTIVAL DISEASE USING OCULAR SURFACE TISSUE, AND AGING BIOMARKERC12Q 1/689, C12Q 1/06Filed as OTSUKA PHARMACEUTICAL CO., LTD.2025-06-16Kohji NISHIDA | pending |
| VISCOELASTIC COMPOSITIONA61B 1/32, A61L 24/0005, A61L 31/042, A61B 1/015, A61B 1/126, A61B2017/00862, A61L 24/001, A61L 24/043, A61L 24/08, A61L 29/02, A61L 29/043, A61L 29/14, A61L 31/005, A61L 31/028, A61L 31/041, A61L 31/14, A61L 31/145, A61L2400/04, B65D 71/20, B65D 71/32, B65D2571/00185, B65D2571/00203, B65D2571/00265, B65D2571/00277, B65D2571/00296, B65D2571/0066, B65D2571/00716, B65D2571/00845, B65D2571/0087, C08L 5/00, C08L 5/04Filed as Otsuka Pharmaceutical Factory, Inc.2025-06-13Tomonori Yano | pending |
| HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF EPILEPSYA61K 31/506, C07D 403/04, A61P 25/08, C07D 239/34, C07D 239/47, C07D 239/54, C07D 401/04, C07D 401/12, C07D 405/04, C07D 413/04, C07D 417/04, C07D 471/04, C07D 487/04Filed as OTSUKA PHARMACEUTICAL CO., LTD.2025-06-12Tomoichi SHINOHARA | pending |
| METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND FREEZE-DRIED FORMULATIONA61K 31/496, A61K 9/10, A61K 9/19, A61K 47/26, A61K 47/32, A61K 47/38Filed as Otsuka Pharmaceutical Co., Ltd.2025-06-12Shogo HIRAOKA | pending |
| OPTICAL MEASUREMENT SYSTEM AND NON-TRANSITORY STORAGE MEDIUMG01N 15/0211, G01N 15/14, G01N 21/53, G01N 21/01, G01N 21/49, G01N 21/85, G01N2015/0053, G01N2015/0222, G01N2021/0137, G01N2021/4742, G01N2201/08, G01N2201/0826, G01N2201/0833, G01N2201/0846Filed as Otsuka Electronics Co., Ltd.2025-05-30Ikuo WAKAYAMA | pending |
| METHODS OF DISPERSING ARIPIPRAZOLE INJECTABLE PREPARATIONSA61K 9/0019, A61K 31/496, A61P 25/18, A61P 25/24, A61P 25/00, A61K 9/0024, A61K 9/10, A61K 47/02, A61K 47/10, A61K 47/32, A61K 47/38, A61M 5/31513Filed as Otsuka Pharmaceutical Co., Ltd.2025-05-28Kazuya NAKAMURA | pending |
| COMPOUNDS USEFUL FOR THE TREATMENT OF DISORDERS AND METHODS RELATED THERETOFiled as Otsuka America Pharmaceutical Inc.2025-05-22Abdelmalik SLASSI | pending |
| COMPOUNDS USEFUL FOR THE TREATMENT OF DISORDERS AND METHODS RELATED THERETOFiled as Otsuka America Pharmaceutical Inc.2025-05-20Abdelmalik SLASSI | pending |
| COMPOUNDS USEFUL FOR THE TREATMENT OF DISORDERS AND METHODS RELATED THERETOFiled as Otsuka America Pharmaceutical Inc.2025-05-20Abdelmalik SLASSI | pending |
| METHOD OF DENERVATING PULMONARY ARTERYA61B 17/320068, A61N 7/022, A61B2017/320069, A61B2017/00243, A61B2017/00292, A61B2017/22062, A61B2017/22067, A61B2017/22068, A61B2018/00023, A61B2018/0022, A61B2018/00279, A61B2018/00285, A61B2018/00345, A61B2018/00577, A61M 25/10, A61N2007/003, A61N2007/0056, A61N2007/006Filed as OTSUKA MEDICAL DEVICES CO., LTD.2025-05-12Dimitri AUGUSTIN | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on OTSKY
Company overviewEverything on OTSKY in one place, with the price.Who owns itEvery manager reporting a position in OTSKY.LobbyingWhat OTSKY spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on OTSKY's account, and who they worked for.Federal contractsWhat federal agencies pay OTSKY.